Welgene Biotech Co.,Ltd. (TPEX:6661)
Taiwan · Delayed Price · Currency is TWD 17.80
-0.15 (-0.84%)
May 8, 2026, 1:23 PM CST
Welgene Biotech Market Cap
Welgene Biotech has a market cap or net worth of 414.82 million as of May 8, 2026. Its market cap has decreased by -21.93% in one year.
Market Cap
414.82M
Enterprise Value
378.29M
Revenue
375.94M
Ranking
n/a
PE Ratio
311.89
Stock Price
17.80
Market Cap Chart
Since October 23, 2017, Welgene Biotech's market cap has decreased from 575.10M to 414.82M, a decrease of -27.87%. That is a compound annual growth rate of -3.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 414.82M | -4.30% |
| Dec 31, 2025 | 433.46M | -21.85% |
| Dec 30, 2024 | 554.64M | 6.49% |
| Dec 29, 2023 | 520.85M | 0.68% |
| Dec 30, 2022 | 517.35M | -9.20% |
| Dec 30, 2021 | 569.79M | -23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.65B |
| DIVA Laboratories | 1.76B |
| Genetics Generation Advancement | 1.17B |
| Puriblood Medical | 920.68M |
| TFBS Bioscience | 824.56M |
| Kim Forest Enterprise | 788.11M |
| Sofiva Genomics | 703.94M |
| Pharmigene | 491.53M |